The University of Kentucky Alzheimer's Disease Center (UK-ADC) was founded in 1985, prior to the advent of biomarker initiatives that continue to grow in size and scope. We propose the development of a Biomarker Core to enrich the UK-ADC and provide an infrastructure that will allow us to contribute significantly to the discovery of antemortem biomarkers. The UK-ADC has focused on the early transitions from normal cognitive aging to the development of cognitive impairment. The shift of focus in the AD field to earlier, pre- clinical stages of disease ideally positions our center, which has had a focus on subjects with normal cognition and early detection and tracking of changes associated with degenerative disease states for the last 30 years. As a result, our center has collected over 700 plasma samples, 100 CSF samples, and 250 MRI batteries from cognitively intact individuals. Further, we have over 350 plasma samples, 150 CSF samples and 300 MRI batteries from individuals with mild cognitive impairment. In establishing a biomarker core, we will build an infrastructure that allows us to analyze, distribute and track these valuable current and future biomarker samples. The infrastructure will also provide the means for us to support intramural, extramural, and national biomarker initiatives such as NACC, ADGC/NCRAD, ADNI, ADCS/ATRI and other NIH/NIA initiatives. We will also establish a trial-ready, biomarker-characterized, subject cohort, facilitating enrollment into intramural and extramural clinical translational studies to eliminate recruitment and screen fail bottlenecks. Finally, our center has been at the forefront of research on AD-mimics including hippocampal sclerosis (HS-Aging), primary age- related tauopathies (PART), cerebral age-related TDP-43 and sclerosis (CARTS), and vascular contributions to cognitive impairment and dementia (VCID). As such, the addition of a biomarker core will allow us to continue to contribute to these fields and the rapidly growing interest in biomarker development in these areas. Overall, the bolus of support for our new biomarker core will allow us the increased infrastructure needed to support NIH/NIA initiatives and our researchers needs in the 21st century and beyond.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG028383-13S1
Application #
9356678
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2017-08-15
Budget End
2019-06-30
Support Year
13
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Type
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40526
Gold, Brian T; Brown, Christopher A; Hakun, Jonathan G et al. (2017) Clinically silent Alzheimer's and vascular pathologies influence brain networks supporting executive function in healthy older adults. Neurobiol Aging 58:102-111
Moga, Daniela C; Abner, Erin L; Wu, Qishan et al. (2017) Bladder antimuscarinics and cognitive decline in elderly patients. Alzheimers Dement (N Y) 3:139-148
Van Steenbergen, Anne; Balteau, Magali; Ginion, Audrey et al. (2017) Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart. Sci Rep 7:41166
Fardo, David W; Katsumata, Yuriko; Kauwe, John S K et al. (2017) CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRN. Exp Gerontol 90:83-89
Jiang, Yang; Lin, Ming Kuan; Jicha, Gregory A et al. (2017) Functional human GRIN2B promoter polymorphism and variation of mental processing speed in older adults. Aging (Albany NY) 9:1293-1306
Sennik, Simrin; Schweizer, Tom A; Fischer, Corinne E et al. (2017) Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data. J Alzheimers Dis 55:1519-1528
Kim, Julia; Schweizer, Tom A; Fischer, Corinne E et al. (2017) The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease. J Alzheimers Dis 55:381-389
Neu, Scott C; Pa, Judy; Kukull, Walter et al. (2017) Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis. JAMA Neurol 74:1178-1189
Mattos, Meghan K; Snitz, Beth E; Lingler, Jennifer H et al. (2017) Older Rural- and Urban-Dwelling Appalachian Adults With Mild Cognitive Impairment. J Rural Health 33:208-216
Alosco, Michael L; Duskin, Jonathan; Besser, Lilah M et al. (2017) Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set. J Alzheimers Dis 57:953-968

Showing the most recent 10 out of 390 publications